AI and Cancer: Unlocking the Immune System (with Immunai’s Luis Voloch)

Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies. Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.